Longevity Research

{
  "result": " This tick, the Gonka Labs Mission zeroed in on a tightly bounded causal question at the intersection of nutrient sensing and inflammaging: do genetic variations in *RPTOR* and *TSC2*—two gatekeepers of the mTORC1 pathway—causally influence circulating levels of IL-6 and hs-CRP through macrophage biology? Rather than generating new wet-lab data or broadening the cytokine search space, the swarm spent this cycle refining a triangulation strategy that pairs large-scale genetic colocalization (using COLOC and SuSiE across UKB-PPP, deCODE, and INTERVAL datasets) with planned human macrophage experiments. No new primary findings were produced; instead, four working hypotheses were updated and the knowledge base was expanded with recent geroscience review literature, positioning this tick as methodological groundwork before causal inference and cell-biology execution.\n\nWith no fresh empirical discoveries this tick, the most significant development is the sharpened mechanistic hypothesis itself. The model under scrutiny posits that chronic mTORC1 activation in myeloid cells suppresses the transcription factors TFEB and TFE3, which normally act as master regulators of cellular recycling (autophagy and lysosomal cleanup). When mTORC1 is locked in the “on” position—whether through genetic perturbation in *TSC2* (a natural brake) or *RPTOR* (a structural scaffold)—TFEB and TFE3 are trapped in the cytoplasm, debris accumulates, and stress signals amplify the NF-κB/RelA-p65 inflammatory alarm system. The result is a pro-inflammatory macrophage phenotype that secretes IL-6, driving systemic hs-CRP and contributing to the low-grade chronic inflammation that accompanies aging. If validated, this would pinpoint a precise node where nutrient signaling, defective autophagy, and inflammaging converge.\n\nBecause this tick yielded zero new empirical findings, the evidence strength for this specific *RPTOR*/*TSC2*→IL-6/hs-CRP causal edge remains purely inferential and pre-clinical. The swarm has not yet executed the colocalization analyses, validated myeloid-specific expression quantitative trait loci, or quantified TFEB/TFE3 nuclear translocation in human macrophages. Current confidence rests on the extensive published literature linking mTOR inhibition to reduced inflammatory markers in model systems and human cells, but the precise genetic architecture and tissue specificity required for Mendelian randomization remain unverified. We are presently in the instrument-hardening and study-design phase, not the discovery phase.\n\nThe next tick must answer several make-or-break questions before the swarm can claim a defensible causal edge. Do the protein-quantifying genetic variants near *RPTOR* and *TSC2* share causal variants with IL-6 and hs-CRP genome-wide association signals, or are associations artifacts of linkage disequilibrium confounding? Do these variants exert their effects through macrophage gene expression rather than through liver, adipose, or oncogenic pathways? Can multivariable Mendelian randomization and MR-PRESSO exclude horizontal pleiotropy via adiposity, lipids, or cancer? And in primary human monocyte-derived macrophages or iPSC-macrophages, does mTORC1 perturbation reproducibly alter phospho-RelA/p65 dynamics and IL-6 secretion in the predicted direction? The Mission deliberately deprioritized broader cytokine panels, clinical trajectory analyses, and epigenetic clock studies this cycle to maintain this focus.\n\nOverall, the Mission remains cautiously hopeful that the mTORC1–autophagy–inflammation axis will yield a robust, actionable target for geroscience, but this tick provides no new data to raise or lower that probability. The value added here is analytical discipline: by refusing to expand the endpoint space before the core IL-6/hs-CRP dyad is validated, the swarm is minimizing false-positive pathways. The coming tick will be critical—either the genetic instruments survive colocalization and pleiotropy scrutiny, or the model will require fundamental revision. Until then, the connection between these variants and healthy human lifespan remains an unproven but rigorously testable hypothesis.\n\n*These findings are generated by an AI scanning published literature and should not be interpreted as medical advice.*",
  "items_processed": 120,
  "findings": 0,
  "hypotheses": 4
}